Different Clinical Impact Between Angiotensin-Converting Enzyme Inhibitors and AT1 Receptor Blockers: A Nationwide Cohort Study

被引：0
|
作者：
Chu, Chun-Yuan [1 ]
Lee, Wen-Hsien [1 ]
Hsu, Po-Chao [1 ]
Su, Ho-Ming [1 ]
Lee, Hung-Hao [1 ]
Chiu, Cheng-An [1 ]
Lin, Tsung-Hsien [1 ]
Lee, Chee-Siong [1 ]
Yen, Heueh-Wei [2 ]
Voon, Wen-Chol [1 ]
Lai, Wen-Ter [1 ]
Sheu, Sheng-Hsiung [1 ]
机构：
[1] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung, Taiwan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2016.03.157
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A-127
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [31] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
    Benenson, Irina
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
  • [32] Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
    Cheng-Maw Ho
    Chih-Hsin Lee
    Ming-Chia Lee
    Jun-Fu Zhang
    Jann-Yuan Wang
    Rey-Heng Hu
    Po-Huang Lee
    BMC Cancer, 18
  • [33] Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
    Ho, Cheng-Maw
    Lee, Chih-Hsin
    Lee, Ming-Chia
    Zhang, Jun-Fu
    Wang, Jann-Yuan
    Hu, Rey-Heng
    Lee, Po-Huang
    BMC CANCER, 2018, 18
  • [34] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH HYPERTENSION
    Sanchez, Andres M. Cordova
    Shmorgon, Gary
    Olonoff, Danielle A.
    Ramm, Matthew
    Gualan, Carlos Merino
    Chaudhuri, Debanik
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2074 - 2074
  • [35] Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Raebel, Marsha A.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e156 - e166
  • [36] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [37] Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Koomen, E. R.
    Herings, R. M. C.
    Guchelaar, H. J.
    Nijsten, T.
    CANCER EPIDEMIOLOGY, 2009, 33 (05) : 391 - 395
  • [38] Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study
    Rasmussen, Eva Rye
    Pottegard, Anton
    Bygum, Anette
    von Buchwald, Christian
    Homoe, Preben
    Hallas, Jesper
    JOURNAL OF INTERNAL MEDICINE, 2019, 285 (05) : 553 - 561
  • [39] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Potier, Louis
    Roussel, Ronan
    Elbez, Yedid
    Marre, Michel
    Zeymer, Uwe
    Reid, Christopher M.
    Ohman, Magnus
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    HEART, 2017, 103 (17) : 1339 - 1346
  • [40] COMPARATIVE EFFECTIVENESS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS FOR MAJOR RENAL OUTCOMES: A 15-YEAR NATIONWIDE COHORT STUDY
    Wu, Hon-Yen
    Peng, Chiao-Ling
    Chen, Pei-Chun
    Chang, Chee-Jen
    Peng, Yu-Sen
    Chu, Tzong-Shinn
    Hung, Kuan-Yu
    Chien, Kuo-Liong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
12345